Medical

non-approvable letter

non-approvable letter

An official communication from the US Food & Drug Administration to a New Drug Application (NDA) sponsor, which describes significant deficiencies in the application that require correction before the application can be considered by the FDA.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive
The FDA issued a non-approvable letter in August last year as a result of what the agency considered flaws in the clinical trial's patient population.
Daiichi Sankyo further said that the submission reflects the conclusion of a clinical study programme designed to investigate the risk profile of Injectafer following FDA's issuance of a non-approvable letter in March 2008 with respect to the original NDA submission.
The Food and Drug Administration issued a non-approvable letter for the company's lead candidate, antipsychotic drug iloperidone.
But Jerini has run into trouble with the FDA, which issued a non-approvable letter on the therapy.
In August 2004, the FDA issued a non-approvable letter, going against the panel's recommendation.
So, for the FDA to come out with a non-approvable letter was quite unusual, given the strong agreement in favor of over-the-counter approval at every level and of the Advisory Committee.
NORDIC BUSINESS REPORT-24 June 2002-Astra-Zeneca receives non-approvable letter for Casodex (C)1994-2002 M2 COMMUNICATIONS LTD http://www.m2.com
Merck spokesman Ron Rogers declined to comment on why the FDA sent the non-approvable letter or what added information the company would provide to regulators.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.